Navigation Links
Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
Date:2/28/2008

any had debt of $2.1 billion, down approximately $600 million from December 31, 2006.

EBITDA

Earnings from continuing operations before interest, taxes, depreciation and amortization (EBITDA), for the quarter and the year ended December 31, 2007 totaled $148 million and $607 million, respectively. Please see the reconciliation table at the end of this press release for the calculation of EBITDA.

2008 Financial Outlook

The Company expects adjusted earnings per fully diluted share for 2008 to be in the range of approximately $3.05 - $3.35. The adjustments are discussed in the paragraph immediately below. The Company expects total revenues for 2008 to be in the range of $2.7 - $2.8 billion, including total product sales in the range of $2.55 - $2.65 billion. On the expense side for 2008, the Company expects R&D investment of approximately $265 - $280 million, and SG&A expenses to be approximately $810 - $830 million.

The Company's adjusted earnings guidance for 2008 excludes the impact of amortization costs associated with acquired products, contributions and/or losses from the DDDI operations that the Company plans to divest and incremental depreciation related to purchase accounting. The Company's adjusted guidance also excludes the impact of any unscheduled launches resulting from patent challenges, other business development activities, and refinancing activities that may be completed after the date hereof and on or before December 31, 2008. In contrast to 2007, the Company's adjusted earnings guidance for 2008 does not add back stock compensation expense. The change in the Company's presentation of adjusted earnings results in a reduction of the estimated earnings for 2008 by approximately $0.20 per share.

Conference Call/Webcast

The Company will host a conference call at 8:30AM Eastern time on Thursday, February 28 to discuss results for the quarter and year ended December 31, 2007. The number to call from within t
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... VANCOUVER , Aug. 26, 2015 /PRNewswire/ - iCo ... ICOTF), today reported financial results for the quarter ... are expressed in Canadian dollars and presented under ... continue pre-clinical activities with respect to our Oral ... of a contract manufacturer," said Andrew Rae ...
(Date:8/26/2015)... 2015  Platform therapeutic company Symic Biomedical, Inc. ... $1.5M Phase II SBIR grant from the National ... therapeutic agent to reduce arteriovenous fistula (AVF) failures, ... renal disease (ESRD) patients undergoing hemodialysis. The two-year ... and Digestive and Kidney Diseases (NIDDK), will allow ...
(Date:8/26/2015)... After litigating and negotiating patent infringement ... P2i United States patent RE43,651 (the ... the United States without any admission or ... party. As a result of the parties, settlement, the US ... dismissed the case without prejudice. Under ...
(Date:8/25/2015)... SHANGHAI , Aug. 25, 2015   WuXi ... open-access R&D capability and technology platform company serving the ... Holdings Ltd. ("Lee,s Pharm," Hong Kong Exchange Stock Code: ... Hong Kong with 20 years of operations ... the two companies have signed an agreement whereby WuXi,s ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3P2i Settles United States Litigation 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 3
... CLARA, Calif., Oct. 10 Finesse Solutions, LLC, ... science process,applications, is pleased to announce improvements to ... transmitters even easier. The E-Store,can be found at ... now easily purchase bioprocess sensors and accessories,on-line, anywhere ...
... England, Oct. 10 Twenty of Britain,s most,innovative ... their,ideas at the fifth annual SETsquared Partnership Showcase ... Great George Street, London, from 8am on,Thursday, October ... electronics, information technology, engineering and biotechnology., Six ...
... October 10 , - Ranked Number 7 out ... Merck Serono, a division of Merck KGaA, Darmstadt, Germany, ... as a top employer in the,biotechnology and pharmaceutical industries, ... the life sciences., "We are honored that the ...
Cached Biology Technology:Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 2Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 3Merck Serono Named as a Top Employer by Science Magazine 2
(Date:8/12/2015)... , August 12, 2015 As ... mobile payment innovation and advanced biometrics technology is accelerating ... way consumers rely on using their credit cards, the ... the future for payment services led by companies in ... ), :  Google, Inc. (NASDAQ: GOOG ), Apple ...
(Date:8/10/2015)... and TELTOW, Germany , August ... (SMI), a world leader in Eye Tracking Technology ... of its OEM Eye Tracking Platform for integration into ... Platform contains reference designs for seamless integration of eye ... virtual reality HMDs and augmented reality smart glasses. Omnivision,s ...
(Date:8/6/2015)... Calif. , Aug. 6, 2015 ... developer of human interface solutions, today announced collaboration ... technologies on Windows 10. Microsoft leveraged Synaptics, deep ... the operating system. Through stringent ... are fully certified with Microsoft,s Precision TouchPad (PTP) ...
Breaking Biology News(10 mins):Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... 2011 Recent studies conducted at the Institut de ... PCSK enzymes could have a positive impact on health, ... Nabil G. Seidah, Director of the Biochemical Neuroendocrinology research ... over the past four months, all shedding light on ...
... on cancer, and development of new cancer therapeutics, has ... area of focus is the life and death of ... programmed cell death, is a fundamental process of cells ... apoptosis involve many different proteins and their interactions with ...
... plant species on the Iberian Peninsula had been discovered, ... Taraxacum lacianense , two dandelions from the Pyrenees ... confirms Spain,s privileged position as a hotbed of biodiversity. ... Spain. It depends on the complexity of the group ...
Cached Biology News:1 group of enzymes could have a positive impact on health, from cholesterol to osteoporosis 21 group of enzymes could have a positive impact on health, from cholesterol to osteoporosis 3Designing new molecular tools to study the life and death of a cancer cell 2Designing new molecular tools to study the life and death of a cancer cell 3Designing new molecular tools to study the life and death of a cancer cell 42 new plants discovered in Spain 2
... of the human Topoisomerase II gene. ... state of nucleic acids by passing an intact ... a separate DNA helix (1,2) . As a ... enzyme can relax negatively or positively supercoiled DNA, ...
Maxi XL Hybridization Oven for Extra Large bottles. 6 bottle (70 mm) rotisserie + shaker tray available for simultaneous use. Includes linear and orbital shaker trays, 4 extra large bottles, pack o...
... Kit - Monolayer is a system designed for ... monolayer in a serum-free environment. The kit contains ... has been optimized for neural stem cell expansion ... & Development 10 :3129). Human fibroblast growth ...
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
Biology Products: